High Q Technologies, a leader in quantum-enabled scientific instruments, has proudly announced the commercial launch and initial sale of its groundbreaking FATHOM EPR Spectrometer. This innovative tool is set to revolutionize the approach to protein dynamics and drug discovery by enabling automated, precise measurements critical for understanding complex biological structures.
Unveiling the FATHOM EPR Spectrometer
The new FATHOM EPR Spectrometer opens avenues for structural biologists and drug hunters by offering an automated solution for measuring dipolar distance distributions within proteins. This capability is crucial for revealing intricate details about protein conformations and dynamics, potentially accelerating advancements in medical research and pharmaceutical development. The device features a 5-sample cartridge that automates loading, calibration, measurement, and analysis, affording researchers more time to focus on the biochemistry of their samples.
First Sale and Expert Endorsements
The first unit of the FATHOM spectrometer has been sold to an esteemed consortium led by Prof. Reza Dastvan of Saint Louis University School of Medicine, who is at the forefront of research in various diseases. Prof. Dastvan expressed excitement about integrating this state-of-the-art technology into his lab, highlighting its potential to expedite crucial health research. Rudra Maharajh, Director of Product Management at High Q, echoed this sentiment, noting the tool’s capacity to significantly enhance research efficiency.
Key Features and Technological Advancements
The FATHOM EPR Spectrometer boasts several key features that set it apart from traditional EPR systems. These include:
- Automated calibration, measurement, and analysis of up to five samples simultaneously using SQBA™ Sample Cartridges.
- A significantly reduced sample volume requirement, offering more than a tenfold decrease compared to other devices.
- A fully integrated system that supports automated sample loading and operates without the need for cryogenics.
These enhancements promise to transform the landscape of EPR spectroscopy, aligning it with contemporary needs in scientific research.
In summary, High Q Technologies’ release of the FATHOM EPR Spectrometer marks a significant milestone in the fields of biophysics and drug discovery. With its first sale already in the books and the endorsement of key figures in the scientific community, FATHOM is poised to become an essential tool in advancing human health research. Its automated capabilities and advanced features not only ensure high precision but also ease the complexities traditionally associated with EPR spectroscopy.
Don’t miss our latest Startup News: RuggON’s VORTEX: Powering Industries with Rugged Tech
